Clearstead Trust, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Clearstead Trust, LLC
- $526 Million
- Q3 2025
A detailed history of Clearstead Trust, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Clearstead Trust, LLC holds 33 shares of AMPH stock, worth $859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33
Previous 33
-0.0%
Holding current value
$859
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
262Shares Held
33.5MCall Options Held
73.4KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$155 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$68.6 Million0.0% of portfolio
-
Td Asset Management Inc1.93MShares$50.3 Million0.05% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.76MShares$45.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.5MShares$39.1 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.28B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...